
	Prior to FORUM, Mr. Shegog served as Senior Vice President, Finance and Chief Financial Officer at Millennium Pharmaceuticals, Inc., now Millennium: The Takeda Oncology Company, where he was responsible for management of the company&rsquo;s financial resources, corporate planning, financial reporting and compliance. During his tenure from 1998 to 2014, Mr. Shegog held key leadership roles supporting the early evolution of the company and its transformation from a genomics company to a fully-integrated drug developer, the approval and launch of its flagship oncology product, VELCADE&reg;, and the $8.8 billion acquisition of Millennium by Takeda Pharmaceuticals. He began his career in healthcare at Genetics Institute (now Pfizer) in a variety of financial positions supporting its research and development organizations, and was a member of the Commercial Operations team that supported the launch of BeneFIX&reg;. Mr. Shegog holds an M.B.A. from the Tepper School of Management, Carnegie Mellon University and a B.S. degree in electrical engineering from Lafayette College.
